Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Change in Account Payables (2021 - 2022)

Updated

Gain Therapeutics' Change in Account Payables came in at -$643,164 for FY2023, compared with $1.07 million in FY2022.

Analysis

Gain Therapeutics (GANX) Change in Account Payables (2021 - 2022) Analysis & Trends

Going back to FY2020, Gain Therapeutics' Change in Account Payables data covers 4 years.

  • Per Business Quant, earlier years put Change in Account Payables at $1.07 million in FY2022, -$521,394 in FY2021 and $395,543 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,141.09 Bn 1,109.67 Bn 19.71 Bn -
2 Johnson & Johnson 635.15 Bn 555.01 Bn 17.30 Bn -
3 AbbVie 501.95 Bn 475.07 Bn 12.70 Bn -
4 Merck 356.40 Bn 310.78 Bn 12.21 Bn -
5 Novartis Ag 300.55 Bn 264.54 Bn 11.24 Bn -
6 Astrazeneca 263.27 Bn 236.95 Bn 12.86 Bn -
7 Amgen 237.82 Bn 193.22 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 194.11 Bn 168.30 Bn 6.22 Bn 18.00 Mn
9 Pfizer 170.27 Bn 116.91 Bn 10.94 Bn -
10 Gain Therapeutics 52.96 Mn -6.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.54 Mn
Mar 31, 2021 82,927.00
API Access

Gain Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=GANX&period=max&api_key=YOUR_API_KEY